Nutrasona

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nutrasona

Property Description
Active Ingredient Hydrocortisone
Form Topical Preparation (Cream, Ointment, Lotion)
Pharmacological Class Glucocorticoid / Corticosteroid
General Purpose Regulation of localized inflammation and associated symptoms
Origin Synthetic

Nutrasona is a pharmaceutical preparation formulated for application directly to the skin, classified as a topical corticosteroid. Its active component is Hydrocortisone, a synthetic agent that is chemically identical to the natural hormone cortisol.

This classification means Nutrasona belongs to the adrenocorticosteroid family, specifically the Glucocorticoid class of medicines. The function of a glucocorticoid is to modulate the body's inflammatory and immune responses. Unlike some high-potency agents, Hydrocortisone is recognized in pharmacological literature as having lower overall anti-inflammatory strength, which positions it for broad application in managing mild to moderate external inflammatory responses. The medication's foundational role is to ease discomfort by calming the body's inflammatory skin reaction, a benefit clinically recognized for its established safety profile in topical therapy.

Understanding the Composition and General Purpose

The composition of Nutrasona centers on Hydrocortisone as the single active ingredient, delivered via a topical preparation supplied typically as a cream, ointment, or lotion. These high-level dosage forms utilize specialized dermatological vehicles (bases) that are engineered to ensure effective transfer of the Hydrocortisone into the targeted layers of the skin. The general therapeutic purpose of Nutrasona is to regulate and suppress localized inflammation, providing relief from the common, uncomfortable symptoms associated with irritation, such as redness, swelling, and persistent itching.

Regulatory References

  1. Cortisol Physiology and Function
  2. Hydrocortisone Topical Drug Information

What side effects are possible with Nutrasona?

Nutrasona contains the topical corticosteroid hydrocortisone buteprate, and its safety profile is defined by the potential for both local skin reactions and, with extensive use, systemic absorption.

Adverse Reactions and Side Effects

Adverse reactions are primarily associated with the skin and the body's hormonal system. Local reactions include burning, stinging, irritation, itching, dryness, and sometimes skin discoloration or atrophy (thinning). If local skin infections are present, use of this medication may worsen them, requiring separate, specific treatment.

Serious and Clinically Significant Risks

The primary serious concern is systemic absorption, which can lead to suppression of the hypothalamic-pituitary-adrenal (HPA) axis and, in rare instances, manifestations of Cushing's syndrome. This risk is significantly increased by using the product over large skin areas, for prolonged periods, or under occlusive dressings. Potential systemic effects also include ocular conditions such as glaucoma and the formation of posterior subcapsular cataracts. HPA axis function may be monitored in patients at high risk.

Safety Restrictions and Contraindications

Nutrasona is contraindicated in patients with a known hypersensitivity to the active ingredient or excipients, and must not be used on the treatment area if specific conditions are present, including:

  • Viral infections (such as herpes simplex or varicella).
  • Bacterial or fungal infections (unless concomitantly treated).
  • Tuberculosis, syphilis, or ulcers.
  • Rosacea, perioral dermatitis, or acne.

Use is generally discouraged on the face, groin, and underarms unless directed by a healthcare provider. The product is not recommended for use in infants under 2 years of age, and its use in older children must be strictly limited due to their increased susceptibility to systemic side effects like growth retardation.

Overdose and Emergency Response

Overdose and when to seek help

Overdose with Nutrasona is associated with a severe risk of hepatotoxicity (liver damage), which can progress to acute liver failure and potentially be fatal. This risk is primarily dose-dependent and can occur after taking a single very large dose or repeated doses higher than recommended (supra-therapeutic doses).


Documented Overdose Profile

Initial signs of an overdose can be misleading. Symptoms like nausea, vomiting, sweating, anorexia, and abdominal pain may be mild or completely absent for many hours following ingestion. The full extent of liver injury and serious clinical manifestations, such as jaundice (yellowing of the skin/eyes) and confusion, may be delayed and might not become apparent until 18 to 96 hours after the initial exposure.


Immediate Emergency Action Required

Immediate medical attention must be sought (by contacting a poison control center or emergency department) if an overdose is suspected, even if no symptoms are currently present. Due to the delayed nature of the toxicity, timely treatment is critical. The necessary medical response involves the prompt administration of the antidote, N-acetylcysteine (NAC). This treatment is most effective when initiated as soon as possible, ideally within the first 8 hours after the acute overdose, to mitigate the risk of irreversible liver damage.

Therapeutic Uses of Nutrasona

What Nutrasona Treats: Main Uses and Benefits

Nutrasona is generally applied in addressing symptoms related to inflammatory or irritative states of the skin, serving as a topical anti-inflammatory agent. The medication is commonly used to provide relief for localized symptoms arising from these irritative conditions.

The medication is commonly used across conditions involving inflammatory or irritative processes, such as eczema (atopic dermatitis), contact dermatitis, and mild presentations of psoriasis. It provides additional symptomatic support, relevant when symptoms become more noticeable during flare-ups and periods of symptomatic escalation.

The primary therapeutic focus is on providing supportive relief for symptom clusters that may become intense or disruptive. Nutrasona is commonly used to help with the pronounced symptoms of pruritus (itching), erythema (redness), and localized edema (swelling). This offers symptomatic relief that helps patients cope more steadily with symptom fluctuations.

“Applied during phases of increased discomfort, Nutrasona contributes to improved comfort during periods of heightened symptoms.”

Contexts of Episodic and Everyday Use

Nutrasona is considered relevant when short-term symptomatic assistance is needed for common scenarios, including reactions to insect bites and stings and mild seasonal irritations. This low-potency preparation assists with maintaining functional stability for both adults and specific pediatric cases (under medical guidance, e.g., nappy rash), supporting general well-being.

Quick Fact: Relief for Inflammatory Symptoms Nutrasona may assist with managing symptoms that become disruptive, such as itching and redness, which are characteristic of mild to moderate skin inflammation.

Regulatory References

  1. NIH MedlinePlus overview of Hydrocortisone Topical

Eligibility and Restrictions for Use

Official Eligibility Profile: Who Can and Cannot Use Nutrasona Cream

The eligibility profile for Nutrasona 1 mg/g Cream (hydrocortisone buteprate) is defined by official regulatory documents that establish specific restrictions, contraindications, and required cautions for its use.

Populations for Whom Use is Contraindicated:

  • Individuals with a documented allergy or hypersensitivity to hydrocortisone buteprate or any other component listed in the medicine.
  • Individuals with certain skin conditions, including perioral dermatitis, acne, rosacea, or primary skin infections caused by viruses (e.g., herpes, chickenpox), bacteria, fungi, or parasites.

Age and Physiological Restrictions:

  • Children under two years old are strictly excluded from use, as the product's safety and dosage have not been established in this age group.
  • Use is not recommended during the first trimester of pregnancy.
  • Application to large skin areas, prolonged use, or use under occlusive dressings should be avoided during both pregnancy and lactation.
  • For children and adolescents (2 years and older), use is restricted to the shortest possible duration, requiring caution due to the risk of systemic absorption.

Eligibility-Context Constraints:

  • The cream must not be used in the eyes, on mucous membranes, or on open wounds, as defined in official labeling.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for topical hydrocortisone, the active ingredient in Nutrasona, indicates that formal drug–drug interactions are generally not documented for this low-potency topical preparation. This is due to minimal systemic absorption upon appropriate application, which results in plasma concentrations that are typically too low to cause metabolic or transporter-mediated interactions.

Interaction-Related Cautions

The primary focus of regulatory caution is the risk of additive pharmacodynamic effects, not metabolic interference.

  • Additive Glucocorticoid Exposure: The concurrent use of Nutrasona with any other corticosteroid products (e.g., higher-potency topical steroids or systemic preparations) may result in an additive effect. This combination increases the overall potential for systemic adverse effects, including the risk of Hypothalamic-Pituitary-Adrenal (HPA) axis suppression.
  • Physical Absorption Modifiers: The extent of absorption is officially documented to be significantly increased by certain physical factors. Applying the product under occlusive dressings (e.g., bandages, wraps) or to extensive areas of the body or areas with impaired skin barriers can lead to augmented systemic exposure, thereby heightening the potential for additive effects with other glucocorticoids.

Contraindications and Timing Rules

Regulatory labels do not list any medicines as formal systemic drug–drug contraindications for co-administration with topical hydrocortisone. Furthermore, there are no explicit mandatory timing rules (e.g., separation by a specific number of hours) documented for this topical product.

Mechanism of Action

Direct Modulation of Genetic Control and Receptor Binding

This mechanism begins with the Hydrocortisone molecule acting as an agonist at the intracellular Glucocorticoid Receptor ( GR), which is a master transcription factor. By translocating to the cell nucleus, the activated receptor complex performs transrepression to silence pro-inflammatory gene expression (like NF-kappa B) and transactivation to upregulate anti-inflammatory proteins, which initiates the sequence of anti-inflammatory gene regulation.


Interruption of Pro-inflammatory Mediator Cascades

The genetic action triggers the synthesis of Annexin A1, which in turn inhibits the enzyme Phospholipase A2 ( PLA2). Blocking PLA2 prevents the release of Arachidonic Acid, thereby restricting the activity of a primary biochemical pathway that generates inflammatory mediators like Prostaglandins and Leukotrienes. This results in a substantial reduction in local inflammatory chemical signaling.


Regulation of Local Tissue and Vascular Responses

The final mechanistic domain involves the drug's effect on peripheral tissues, resulting in local vasoconstriction and a decrease in capillary permeability. Additionally, the mechanism suppresses the migration, accumulation, and activity of key immune cells (leukocytes) at the application site. This physiological consequence limits local fluid leakage and cell infiltration associated with overactive inflammatory responses, contributing to pathway modulation.

Dosage and Administration Information

Official Administration Guidelines

Nutrasona, a topical preparation containing hydrocortisone, is used according to specific instructions to ensure proper application and absorption.

Administration Scope Official Requirement
Route of Administration Topical (for external use only).
Dosing Schedule Apply a thin film of the preparation to the affected skin area.
Frequency Pattern Typically applied one to four times daily, depending on the specific strength and product formulation.
Duration Limit Over-the-counter use is generally limited to no more than 7 consecutive days without consultation with a healthcare professional.

Procedural and Population Rules

Administration of the medicine follows a specific procedural structure focused on the application method. The treated area should not be bandaged, covered, or wrapped unless specifically directed by a physician, as occlusive dressings can increase the medicine's absorption.

For age-specific administration, usage guidelines restrict use in children under 2 years of age unless explicitly instructed by a physician. When applying the medicine to an infant's diaper area, tight-fitting diapers or plastic pants should be avoided, as these act as occlusive coverings.

If a dose is missed, guidelines advise to apply it as soon as it is remembered, then return to the regular dosing schedule; the user should not apply a double amount to make up for the missed application.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Nutrasona

Evidence for Use in Atopic Dermatitis (Eczema)

The evidence base for Nutrasona's application in atopic dermatitis primarily comes from short-term Randomized Controlled Trials (RCTs). The research examined studies conducted during periods of increased symptom activity in adults, children, and infants included in the trials with mild to moderate disease severity. The outcomes monitored focused on clinical measurements and patient-reported outcomes describing discomfort, such as itching and redness.

The short-term trials reported that when compared to a non-active vehicle (placebo), the agent was studied for changes measured in both investigator-rated disease scores and patient reports. Systematic reviews contain data show patterns related to how symptoms evolved in the observed populations. Evidence is limited regarding long-term effects of continuous use, and long-term outcomes are not fully established.

Evidence for Use in Contact Dermatitis

Research for the use of Nutrasona in contact dermatitis includes short-term RCTs and experimental patch-test models that explored short-term symptom changes. Study outcomes examined were linked to inflammatory or irritative states, focusing on the resolution of physical discomfort like redness and swelling within short observation periods.

Trials have described patterns where the application of the agent was studied for changes observed in the signs of acute contact reactions. Findings were mixed concerning the consistency of findings across all specific types of irritant contact dermatitis, and evidence provides limited insight into the long-term impact on the skin barrier.

Evidence for Use in Mild Psoriasis

Nutrasona was studied for use in patients with mild or localized psoriasis. The evidence is derived from short-term RCTs and systematic reviews covering general topical corticosteroid use. Studies monitored outcomes related to physical discomfort, specifically tracking scales that focus on localized plaque characteristics like thickness and scaling. Regulators rely on this evidence base to categorize the agent as relevant for certain corticosteroid-responsive dermatoses. Follow-up durations were limited, and comparative evidence is lacking, as clinical investigation often centers on more potent agents.

Key Studies & References Hydrocortisone Topical (MedlinePlus – NIH)

Frequently Asked Questions (FAQ)

Common questions about Nutrasona (FAQ)


Q: How does Nutrasona compare generally to other medications used for similar conditions?

Official regulatory documents classify topical hydrocortisone, the active component in Nutrasona, as a mild corticosteroid. These medicines are categorized into four potency classes: mild, moderately potent, potent, and very potent. This classification informs healthcare providers of the product's relative strength when selecting treatment.


Q: Does Nutrasona cause long-term problems or dependencies?

Prolonged use, use over large areas, or use under occlusive dressings may lead to serious long-term problems resulting from systemic absorption. These risks include thinning of the skin, ocular conditions like cataracts or glaucoma, and HPA axis suppression. Official labeling does not contain information regarding a potential risk of dependency or addiction for this topical preparation.


Q: Is it true that Nutrasona only works for certain groups of people?

Official guidelines define strict eligibility criteria, which means the product is only intended for use by certain populations. For instance, the medicine is generally not recommended for children under 2 years of age and is contraindicated for use on skin affected by specific conditions like viral infections, acne, or rosacea. These factors establish the patient populations for whom the product is intended.


Q: How reliable is the evidence that supports the use of Nutrasona?

Official information states that the evidence base relies primarily on short-term Randomized Controlled Trials (RCTs), which support its use for short-term symptom relief. However, regulatory documents often note that evidence is limited regarding the safety and effects of continuous, long-term use.


Q: Is Nutrasona ever used in combination with other prescription drugs for the same condition?

Regulatory labels specifically caution against the concurrent use of Nutrasona with any other corticosteroid product. The concurrent use of multiple corticosteroids may increase the risk of systemic side effects, such as HPA axis suppression, due to an additive effect of the glucocorticoid exposure.


Q: If I have allergies, do I need to worry about the inactive ingredients in Nutrasona?

Yes. Official regulatory labels state that the product is contraindicated if a person has a known allergy or hypersensitivity not just to the active ingredient, but to any other component listed in the medicine. Official guidance recommends checking the inactive ingredients listed on the official label.


Q: What exactly is Nutrasona used for, besides the main thing mentioned?

Beyond conditions like eczema and mild psoriasis, official documents indicate Nutrasona is also used for the temporary relief of itching and inflammation associated with a variety of minor irritations. These uses include rashes caused by poison ivy, insect bites, detergents, jewelry, cosmetics, and external anal or genital itching.


Q: Is Nutrasona classified as a controlled substance in any country?

Nutrasona is a topical medicine classified as a Glucocorticoid (corticosteroid). According to official international drug control schedules, it is not listed or classified as a controlled substance.


Q: Why do some people say they felt tired when first starting Nutrasona?

Unusual tiredness or weakness is listed in regulatory information as a potential symptom of systemic adverse effects, such as problems with the adrenal glands or high blood sugar. Official labeling indicates this effect is rare with topical use and is associated with systemic absorption that may occur due to excessive or prolonged application.


Q: Can you take Nutrasona if you have a sensitive stomach?

Nutrasona is a topical preparation applied to the skin, which results in minimal absorption into the body's general system. Gastrointestinal symptoms like stomach upset or nausea, often associated with oral medicines, are not commonly reported with the topical form.


Q: Are there any common foods or supplements that should be strictly avoided while on Nutrasona?

Due to minimal systemic absorption, clinically relevant drug interactions with food or supplements are rare with the topical form. Regulatory guidelines recommend that a healthcare provider be informed about all supplements, vitamins, and foods being consumed.


Q: Is it safe to use Nutrasona if I also take over-the-counter pain relievers?

Clinically relevant drug interactions are considered rare with topical hydrocortisone due to its minimal systemic absorption. Official guidelines recommend informing a healthcare provider about all prescription and non-prescription medicines being used.


Q: I've heard Nutrasona can affect sleep. Is this a common experience?

Sleep problems, such as restlessness or trouble sleeping, are listed as potential signs of serious systemic adverse effects that can result from excessive or prolonged use. If these issues occur, they may be a symptom of conditions like the development of Cushing’s syndrome.


Q: What happens if Nutrasona doesn't seem to be working at all?

Regulatory guidelines indicate that a healthcare provider should be contacted if the condition being treated worsens or if symptoms do not improve within a few days. The provider should also be contacted if symptoms clear up and then return within a short period.


Q: Do people usually stop taking Nutrasona suddenly, or is it a gradual process?

Official warnings state that abrupt discontinuation of the topical corticosteroid can lead to a rebound effect, where the pre-existing skin condition may worsen. Any change in use, including stopping treatment, should be discussed with a healthcare provider.


Q: Are there any known issues with Nutrasona and driving or operating machinery?

Specific warnings against driving are not typically included in the topical hydrocortisone labeling due to minimal absorption. However, dizziness is listed as a potential systemic side effect, and caution may be necessary if a side effect occurs that affects concentration or alertness.


Q: What kind of research has been done on Nutrasona for use in older patients?

Official information notes that natural thinning of the skin occurs in older adults, and therefore, corticosteroids should be used sparingly and for short periods of time in this group. Some regulatory resources indicate that specific data on the effects in geriatric patients may be limited.


Q: Does Nutrasona interact with caffeine or energy drinks?

Clinically relevant interactions with caffeine or energy drinks are considered rare with topical hydrocortisone due to its minimal systemic absorption. No specific regulatory warning is provided for these substances.


Q: Are there specific symptoms that warrant calling a doctor immediately while taking Nutrasona?

Symptoms of potential systemic adverse effects include signs such as blurred vision, dizziness or fainting, a fast or irregular heartbeat, or unusual tiredness and weakness. These signs may be related to high blood sugar or adrenal gland problems.


Q: Is it safe for a man who is planning to father a child to take Nutrasona?

While topical absorption is minimal, systemic corticosteroids have been observed to impair fertility in male rats in animal studies. Official guidelines generally recommend caution regarding use on the external genitalia due to the increased risk of absorption in that area.


Q: Is it normal to feel a bit nauseous in the first week of taking Nutrasona?

Nausea is listed in regulatory information as a potential symptom of systemic adverse effects, such as adrenal gland problems. This effect is not commonly reported with the topical form but may occur due to systemic absorption from excessive or prolonged application.


Q: Does Nutrasona affect blood pressure or heart rate?

High blood pressure and a fast or irregular heartbeat are listed as potential signs of serious systemic adverse effects that can result from excessive or prolonged use. These effects relate to the suppression of the adrenal glands or the development of Cushing’s syndrome.


Q: Does Nutrasona have a 'half-life' and what does that mean for the user?

Yes, hydrocortisone has a half-life of approximately 100 minutes. The half-life refers to the time it takes for the small amount of medication absorbed into the bloodstream to be reduced by half as it is eliminated by the body.


Q: Can Nutrasona be taken with alcohol, based on official warnings?

Specific warnings regarding alcohol are rare for topical hydrocortisone due to its minimal systemic absorption. Regulatory guidelines generally recommend that the use of any medicine in combination with alcohol be discussed with a healthcare professional.


Q: Are there any warnings about Nutrasona and pre-existing kidney or liver conditions?

Regulatory warnings advise that the risk of systemic side effects is greater for patients who have liver failure, as the liver is involved in processing the medication. Regulatory warnings recommend that patients with pre-existing kidney or liver conditions inform their healthcare provider.


Q: Is it possible for a side effect of Nutrasona to appear months after starting it?

Yes. Serious side effects resulting from systemic absorption, such as skin thinning, stretch marks, HPA axis suppression, or the formation of cataracts, are known to develop over time with prolonged use, potentially appearing months after treatment begins.


Q: What is the risk of Nutrasona interacting with herbal supplements like St. John's Wort?

Clinically relevant drug interactions with herbal supplements are considered rare with topical hydrocortisone due to minimal systemic absorption. Regulatory guidelines recommend that a healthcare provider be informed about all herbal products and supplements being used.


Q: Has Nutrasona been approved in Europe or other major regions, or just the US?

Yes. Hydrocortisone topical is approved and has official regulatory data available from government agencies across various regions, including the US (FDA), Europe (UK MHRA/emc), Australia (NPS), and New Zealand (Medsafe).


Q: If I take multiple medications, what's the best way to check for all possible Nutrasona interactions?

Regulatory bodies recommend that a healthcare provider (such as a doctor or pharmacist) be informed about all prescription and non-prescription medicines, vitamins, and supplements being used. This ensures all potential interactions are reviewed by a medical professional.


Q: What should I know about Nutrasona if I plan to have surgery?

Regulatory warnings recommend that patients inform their healthcare provider if they plan to have surgery. The potential systemic side effect of adrenal insufficiency can become worse when the body is under stress, such as from fever, trauma, or surgery.

How should Nutrasona be stored and disposed of?

How to Store and Dispose of Nutrasona?

Nutrasona (Hydrocortisone Topical) must be stored strictly according to regulatory labeling to maintain its stability. The product should be kept at controlled room temperature (20 C to 25 C), away from excess heat, moisture, and direct light. It is essential not to freeze the medicine. Always store the product in its tightly closed, original container and secure it out of the sight and reach of children.

A specific warning advises users not to smoke or go near a naked flame due to the fire risk from fabrics contacting the product. For disposal, unused or expired Nutrasona should ideally be taken to a drug take-back program. If unavailable, the product must be mixed with an undesirable substance, placed in a sealed container, and thrown in the household trash; it must not be flushed down any drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nutrasona found in:

A-Z Index: